Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.

Carlo Patrono, Bianca Rocca

Research output: Contribution to journalArticle

80 Citations (Scopus)


Antiplatelet drugs provide first-line antithrombotic therapy for the management of acute ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their recurrence. Their role in the primary prevention of atherothrombosis remains controversial because of the uncertain balance of the potential benefits and risks when combined with other preventive strategies. The aim of this consensus document is to review the evidence for the efficacy and safety of antiplatelet drugs, and to provide practicing cardiologists with an updated instrument to guide their choice of the most appropriate antiplatelet strategy for the individual patient presenting with different clinical manifestations of coronary atherothrombosis, in light of comorbidities and/or interventional procedures.
Original languageEnglish
Pages (from-to)1760-1776
Number of pages17
JournalJournal of the American College of Cardiology
Publication statusPublished - 2017


  • platelets, antithrombotics, atherothrombosis


Dive into the research topics of 'Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.'. Together they form a unique fingerprint.

Cite this